Petra Jantzer leads Accenture’s Life Sciences Business globally and is the Account CEO for a large global Pharma client. Previously, she led Accenture Life Sciences Europe, R&D Europe, and Life Sciences DACH. Before joining Accenture, Jantzer was a tenured Partner at McKinsey & Company, where she led the R&D practice globally and the Pharmaceuticals & Health practice in Switzerland. On top of that, Jantzer currently serves on the Boards of Directors for both Accenture AG Switzerland and Accenture Services Switzerland.
Jantzer has profound industry and R&D knowledge, deep business process understanding, and two decades of C-level counseling experience to help clients (digitally) transform their businesses. A respected figure in life sciences, she is committed to transforming the industry by harnessing the power of intelligent technologies, such as generative AI, automation and robotics, to drive reinvention at scale. Through these innovative solutions, Jantzer helps life sciences companies unlock breakthroughs in drug discovery, enable faster drug development, personalize patient care, and eliminate costly inefficiencies. Jantzer’s professional roots are in basic science. She holds a PhD in Immuno-Oncology and a master’s in molecular biology.
